A Day Up For DMK Pharmaceuticals Corp Com Par $0.001
Tue, Sep 26, 2023 at 07:59 PM
DMK Pharmaceuticals Corp Com Par $0.001 (DMK:NASDAQ) soared at $0.77, representing a gain of 59.3%. On Tue, Sep 26, 2023, DMK:NASDAQ hit a New 2-Week High of $0.77. The stock appeared on our News Catalysts scanner on Wed, Sep 20, 2023 at 07:35 PM in the 'MISCELLANEOUS' category. From Tue, Sep 12, 2023, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Tue, Sep 26, 2023 at $1.5 with a volume of 59M+.
About DMK Pharmaceuticals Corp Com Par $0.001 (DMK:NASDAQ)
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory...
Top 10 Gainers:
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 504.97%
- Femasys Inc. (FEMY:NASDAQ), 346.32%
- Signature Bank (SBNY:NASDAQ), 105.88%
- Immunovant, Inc. (IMVT:NASDAQ), 97.04%
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Intercept Pharmaceuticals, Inc. (ICPT:NASDAQ), 79.21%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 64.71%
- DMK Pharmaceuticals Corp Com Par $0.001 (DMK:NASDAQ), 59.25%
- Minerva Surgical Inc. (UTRS:NASDAQ), 55.22%
- Acasti Pharma Inc. (ACST:NASDAQ), 37.71%